Necitumumab (IMC-11F8) is a human monoclonal antibody directed against the epidermal growth factor (EGF) receptor, an anti-angiogenic agent used in the treatment of advanced non-small cell lung cancer, and may be used in cancer research.
Purity:
97.90%
CAS Number:
[906805-06-9]
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted